Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curcumin for metabolic syndrome in children
IRCT20181022041407N4Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of curcumin in cardiometabolic risk (CMR), sponsored by Mashhad University of Medical Sciences. Started Jul 2023; status: completed.
02
Drugs
curcumin
03
Conditions
cardiometabolic risk (CMR)
Beyond the preview
Go deeper on IRCT20181022041407N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20181022041407N4.